Josep Argerich
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
G protein-coupled receptor 37 biomarker potential in Parkinson's disease: Inflammation might be the hidden trigger.
Journal: Neural regeneration research
Published: April 24, 2025
B2R-D2R Interaction in Prolactinomas and Nonfunctional Adenomas: Impact on Dopamine Resistance.
Journal: Endocrinology
Published: August 14, 2024
GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate.
Journal: NPJ Parkinson's disease
Published: February 11, 2024
Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells.
Journal: Acta neuropsychiatrica
Published: August 22, 2023
Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 25, 2022
The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A1-A2A receptor heteromer formation and function.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 19, 2022
Ecto-GPR37: a potential biomarker for Parkinson's disease.
Journal: Translational neurodegeneration
Published: November 24, 2020
Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators.
Journal: Molecules (Basel, Switzerland)
Published: February 28, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026